Effects of doxofylline as an adjuvant on severe exacerbation and long‐term prognosis for COPD with different clinical subtypes

Abstract Objective This study aimed to investigate the effectiveness of doxofylline as an adjuvant in reducing severe exacerbation for different clinical subtypes of chronic obstructive pulmonary disease (COPD). Methods The clinical trial was an open‐label non‐randomized clinical trial that enrolled...

Full description

Bibliographic Details
Main Authors: Mei‐Feng Chen, Wei He, De‐Sheng Huang, Hui Jia, Zhao‐Shuang Zhong, Nan Li, Shan‐Shan Li, Shu‐Yue Xia
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:The Clinical Respiratory Journal
Subjects:
Online Access:https://doi.org/10.1111/crj.13670